ATE327800T1 - Behandlung von darm- oder blasenentzündungen - Google Patents

Behandlung von darm- oder blasenentzündungen

Info

Publication number
ATE327800T1
ATE327800T1 AT98934310T AT98934310T ATE327800T1 AT E327800 T1 ATE327800 T1 AT E327800T1 AT 98934310 T AT98934310 T AT 98934310T AT 98934310 T AT98934310 T AT 98934310T AT E327800 T1 ATE327800 T1 AT E327800T1
Authority
AT
Austria
Prior art keywords
treatment
intestinal
bladder inflammation
patient
disclosed
Prior art date
Application number
AT98934310T
Other languages
English (en)
Inventor
Jerome Zeldis
Susan Mclaughlin
Bruce Stouch
Robert Knobler
Original Assignee
Therakos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakos Inc filed Critical Therakos Inc
Application granted granted Critical
Publication of ATE327800T1 publication Critical patent/ATE327800T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0439—White blood cells; Leucocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98934310T 1997-07-10 1998-07-08 Behandlung von darm- oder blasenentzündungen ATE327800T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5210197P 1997-07-10 1997-07-10

Publications (1)

Publication Number Publication Date
ATE327800T1 true ATE327800T1 (de) 2006-06-15

Family

ID=21975478

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98934310T ATE327800T1 (de) 1997-07-10 1998-07-08 Behandlung von darm- oder blasenentzündungen

Country Status (19)

Country Link
US (1) US5985914A (de)
EP (1) EP0994743B1 (de)
JP (1) JP4166432B2 (de)
KR (1) KR100541784B1 (de)
CN (1) CN1230212C (de)
AT (1) ATE327800T1 (de)
AU (1) AU752616B2 (de)
CA (1) CA2295572C (de)
DE (1) DE69834724T2 (de)
DK (1) DK0994743T3 (de)
ES (1) ES2265664T3 (de)
HK (1) HK1030891A1 (de)
HU (1) HUP0004089A2 (de)
IL (2) IL133913A0 (de)
NO (1) NO20000087L (de)
NZ (1) NZ524459A (de)
PL (1) PL196145B1 (de)
PT (1) PT994743E (de)
WO (1) WO1999002215A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0004089A2 (hu) * 1997-07-10 2001-04-28 Therakos, Inc. A bél és a húgyhólyag gyulladásos rendellenességeinek kezelése testen kívüli fotoferezissel
US6495366B1 (en) * 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US8722422B2 (en) 1999-09-03 2014-05-13 Therakos, Inc. Uninterrupted flow pump apparatus and method
WO2002060376A2 (en) * 2001-01-31 2002-08-08 Tolaren Induction of tolerance by apoptotic and/or necrotic cells
US20050202098A1 (en) 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
KR20040096497A (ko) * 2001-11-29 2004-11-16 테라코스, 인크. 체외 광분리반출법 및/또는 세포소멸성 세포를 사용한특정 대상체의 전처리 방법
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
GB0216650D0 (en) * 2002-07-18 2002-08-28 Univ Bristol Detection of disease by analysis of emissions
AU2005311769A1 (en) 2004-12-02 2006-06-08 Isis Pharmaceuticals, Inc. Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease
WO2007004045A2 (en) * 2005-07-05 2007-01-11 Universite De Lausanne Use of a photosensitizing agent in the treatment or prevention of an inflammation-associated disorder in the gastrointestinal tract of a mammal
EP2443922B1 (de) 2005-11-02 2017-05-03 Therakos, Inc. Ex-vivo-Verwendung apoptotischer Zellen zur Erzeugung regulatorischer T-Zellen
JP5295950B2 (ja) 2006-05-02 2013-09-18 セラコス・インコーポレイテッド 移植片対宿主病または移植関連死に対する感受性を検出するための方法および試薬
EP2042179A1 (de) * 2007-09-26 2009-04-01 sanofi-aventis Neue therapeutische Verwendung adrenerger alpha-1-Rezeptorantagonisten
US9399093B2 (en) 2012-01-27 2016-07-26 Fenwal, Inc. Systems and methods for performing online extracorporeal photopheresis
DE102013101989A1 (de) * 2013-02-28 2014-09-18 B. Braun Avitum Ag Fuzzy-Logik
AU2020404121A1 (en) * 2019-12-20 2022-06-23 Mallinckrodt Pharmaceuticals Ireland Limited Method for generating immunoregulatory cells in a blood-derived sample

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196281A (en) * 1976-10-20 1980-04-01 Regents Of The University Of California Psoralens
IT1088554B (it) * 1977-11-17 1985-06-10 F I D I A Spa Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina
US4398906A (en) * 1979-12-11 1983-08-16 Frederic A. Bourke, Jr. Method for externally treating the blood
US4321919A (en) 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4428744A (en) * 1979-12-11 1984-01-31 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4464166A (en) * 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
US4612007A (en) * 1981-06-16 1986-09-16 Edelson Richard Leslie Method and system for externally treating the blood
FR2521998B1 (fr) * 1982-02-25 1985-10-25 Inst Nat Sante Rech Med Pyrido (3,4-c) psoralenes, obtention, applications en cosmetologie et a titre de medicaments et compositions cosmetiques et pharmaceutiques les contenant
FR2521999B1 (fr) * 1982-02-25 1984-05-25 Inst Nat Sante Rech Med Pyrido (3',4' : 4,5) furo (3,2-g) coumarines ou pyrido (3,4-h) psoralenes, obtention, applications en cosmetologie et a titre de medicaments, et compositions cosmetiques et pharmaceutiques les contenant
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5176921A (en) * 1983-05-02 1993-01-05 Diamond Scientific Co. Method of blood component decontamination by glucose addition
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
US4643710A (en) * 1984-10-29 1987-02-17 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4568328A (en) * 1984-10-29 1986-02-04 Extracorporeal Medical Specialties, Inc. Automated photophoresis blood portion control methods and apparatus
US4578056A (en) * 1984-10-29 1986-03-25 Extracorporeal Medical Specialties, Inc. Patient photopheresis treatment apparatus and method
US4573960A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Three phase irradiation treatment process
US4596547A (en) * 1984-10-29 1986-06-24 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4687464A (en) * 1984-10-29 1987-08-18 Mcneilab, Inc. Zero insertion force socket for photoactivation patient treatment system
US4692138A (en) * 1984-10-29 1987-09-08 Mcneilab, Inc. Pump block for interfacing irradiation chamber to photoactivation patient treatment system
US4737140A (en) * 1984-10-29 1988-04-12 Mcneilab, Inc. Irradiation chamber for photoactivation patient treatment system
US4708715A (en) * 1984-10-29 1987-11-24 Mcneilab, Inc. Light array assembly for photoactivation patient treatment system
US4623328A (en) * 1984-10-29 1986-11-18 Mcneilab, Inc. Pump monitor for photoactivation patient treatment system
US4681568A (en) * 1984-10-29 1987-07-21 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4705498A (en) * 1984-10-29 1987-11-10 Mcneilab, Inc. Disposable temperature probe for photoactivation patient treatment system
US4573962A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Cassette drawer assembly for photoactivation patient treatment system
US4573961A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Electronic control methods for puvapheresis apparatus
USD298279S (en) 1986-02-27 1988-10-25 Mcneilab, Inc. Disposable patient fluid irradiation chamber
US4897789A (en) * 1986-02-27 1990-01-30 Mcneilab, Inc. Electronic device for authenticating and verifying disposable elements
USD299531S (en) 1986-02-27 1989-01-24 Mcneilab, Inc. Patient photopheresis treatment unit
USD299953S (en) 1986-02-27 1989-02-21 Mcneilab, Inc. Control panel for a patient photophoresis treatment unit
USD298567S (en) 1986-02-27 1988-11-15 Mcneilab, Inc. Flexible patient fluid container
US4952812A (en) * 1986-08-26 1990-08-28 Baxter International Inc. Irradiation of blood products
US4726949A (en) * 1986-08-26 1988-02-23 Baxter Travenol Laboratories, Inc. Irradiation of blood products
US4866282A (en) * 1986-08-26 1989-09-12 Baxter International Inc. Irradiation of blood products
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4960408A (en) * 1989-01-10 1990-10-02 Klainer Albert S Treatment methods and vaccines for stimulating an immunological response against retroviruses
US5216176A (en) * 1989-01-23 1993-06-01 Lehigh University 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor
US5356929A (en) * 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
US4921473A (en) * 1989-02-02 1990-05-01 Therakos, Inc. Multicomponent fluid separation and irradiation system
US4999375A (en) * 1989-04-11 1991-03-12 Hoffmann-La Roche Inc. Psoralen reagent compositions for extracorporeal treatment of blood
US5383847A (en) * 1990-03-29 1995-01-24 Therakos, Inc. Non-specific immune system enhancement
ES2110002T3 (es) * 1991-06-21 1998-02-01 Baxter Int Procedimiento de inactivacion de agentes patogenos en fluidos corporales.
IL104530A0 (en) * 1992-01-27 1993-05-13 Cryopharm Corp Method of inactivation of viral and bacterial blood contaminants
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
AU4677993A (en) * 1992-08-07 1994-03-03 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
IL105741A0 (en) * 1992-05-22 1993-09-22 Genta Inc Pharmaceutical compositions for treating cellular hyperproliferation using interleukin-1 inhibitory compounds
US5651993A (en) * 1992-11-18 1997-07-29 Yale University Specific immune system modulation
US5820872A (en) * 1992-11-18 1998-10-13 Yale University Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
US5399719A (en) 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
CA2250919C (en) * 1996-03-29 2008-05-13 Therakos, Inc. Photopheresis treatment of leukocytes
HUP0004089A2 (hu) * 1997-07-10 2001-04-28 Therakos, Inc. A bél és a húgyhólyag gyulladásos rendellenességeinek kezelése testen kívüli fotoferezissel

Also Published As

Publication number Publication date
EP0994743A1 (de) 2000-04-26
HK1030891A1 (en) 2001-05-25
IL133913A0 (en) 2001-04-30
DK0994743T3 (da) 2006-10-02
AU752616B2 (en) 2002-09-26
JP2001509427A (ja) 2001-07-24
KR100541784B1 (ko) 2006-01-10
JP4166432B2 (ja) 2008-10-15
EP0994743B1 (de) 2006-05-31
PL196145B1 (pl) 2007-12-31
AU8386498A (en) 1999-02-08
DE69834724D1 (de) 2006-07-06
CA2295572A1 (en) 1999-01-21
EP0994743A4 (de) 2001-02-14
CN1266375A (zh) 2000-09-13
NO20000087L (no) 2000-03-09
DE69834724T2 (de) 2007-05-24
US5985914A (en) 1999-11-16
PL338071A1 (en) 2000-09-25
HUP0004089A2 (hu) 2001-04-28
CA2295572C (en) 2010-07-06
NZ524459A (en) 2004-11-26
IL133913A (en) 2009-09-01
ES2265664T3 (es) 2007-02-16
PT994743E (pt) 2006-08-31
NO20000087D0 (no) 2000-01-07
WO1999002215A1 (en) 1999-01-21
KR20010021630A (de) 2001-03-15
CN1230212C (zh) 2005-12-07

Similar Documents

Publication Publication Date Title
ATE327800T1 (de) Behandlung von darm- oder blasenentzündungen
ATE300298T1 (de) Behandlung von leukocyten durch photopheresis
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69734450D1 (de) Photopherese-behandlung von hcv-infektionen
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
DE60039601D1 (de) Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit
DE69622472D1 (de) Behandlung von Krankheiten durch Induktion von BEF-1 Transkriptionsfaktor
DE69716341D1 (de) Verwendung von Alkanoyl-L-Carnitinen zur Herstellung eines Arzneimittels zur Behandlung von entzündlichen Darmerkrankungen
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
DE69522685D1 (de) Behandlung von blut-plasma
ATE229343T1 (de) Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs
NO984198L (no) FremgangsmÕte for behandling av aggresjon
RU96114051A (ru) Способ лечения экземы у травматолого-ортопедических больных с гнойной инфекцией
RU95105874A (ru) Способ лечения острых тромбозов глубоких вен нижних конечностей
RU95108457A (ru) Способ лечения тяжелых форм глпс
RU94041246A (ru) Способ лечения псориаза
DE69627137D1 (de) Verwendung von pentosan polysulfat zur behandlung von narben in chronischer fortschreitender gefässerkrankungen
RU5055525A (ru) Способ лечения заикания
RU2000100938A (ru) Лечение воспалительных заболеваний кишечника и мочевого пузыря
RU95100165A (ru) Способ лечения прогрессирующей близорукости
RU93037460A (ru) Способ лечения псориаза и пузырчатки

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0994743

Country of ref document: EP